Review of ONTARGET: treating patients at high risk for vascular events with telmisartan, ramipril, or both. Commentary.
Guthrie
Robert M
RM
Department of Emergency Medicine, Ohio State University, Columbus, OH 43212, USA. guthrie.1@osu.edu